Skip to content
ScholarshipUnion Jobs
University of Cambridge logo

University of Cambridge

AstraZeneca-funded PhD: Nanoparticle Targeting of Senescent Lung Alveolar Epithelium

Deadline
8 Dec 2026 · 16 days left
Location
Cambridge, United Kingdom
Type
PhD Position
Compensation
From GBP 21,500 per year
Duration
48 months · 4 years
Start date
1 Oct 2027
Working language
English
Posted
20 Nov 2026
Verified
20 Nov 2026

About this opportunity

The Cambridge Institute for Medical Research (CIMR) at the University of Cambridge offers a four-year, AstraZeneca-funded non-clinical PhD studentship. The project looks at selectively targeting senescent alveolar epithelial cells with nanoparticles, using an alveolar organoid model. The studentship pays a maintenance stipend of £21,500 a year and covers the University composition fee.

What is offered

  • A four-year, fixed-term PhD studentship funded by AstraZeneca, starting 1 October 2027.
  • Maintenance funding of £21,500 per year, plus the University composition fee.
  • Research time split between CIMR and the AstraZeneca Discovery Centre in Cambridge, giving experience in both an academic and an industry setting.
  • Supervision by Dr Jennifer Dickens (CIMR, primary supervisor), with Dr James Garnett and Dr Catherine Overed-Sayer (AstraZeneca). Prof. Ljiljana Fruk will collaborate on the nanoparticle engineering side.
  • A project that combines lung cell biology, cellular senescence, organoid models and nanoparticle-based targeting.

Who can apply

  • Applicants need a first or upper second-class degree from a UK university, or an equivalent overseas qualification, in a subject relevant to cell biology research.
  • You should be highly motivated and able to think and work independently.
  • The studentship is open to UK citizens, and to overseas students who either meet the UK residency rules for home fees or can cover the gap between home and international fees through scholarships or other schemes.
  • You cannot top up the fee funding with your own money (self-funding is not allowed).
  • The University has to confirm that successful candidates have the right to live and work in the UK.

How to apply

  • Apply through the University Application Portal, which is linked from the job page. The list of documents you need is given there.
  • Quote reference number SA51375.
  • The closing date is 8 December 2026.
  • Interviews are expected in December 2026 or January 2027 (dates to be confirmed).
  • Informal enquiries are welcome. Contact Dr Jennifer Dickens at jac72@cam.ac.uk.

Full details are on the official job page.

Requirements

Get new opportunities by email

New listings checked by our editors, as often as you like. Unsubscribe with one click.

Choose types (all by default)
Listing types (none means every type)

We email you a link to confirm first. See our privacy policy.

AstraZeneca-funded PhD: Nanoparticle Targeting of Senescent Lung Alveolar Epithelium

8 Dec 2026 · 16 days left

Apply now

We'd like to use Google Analytics cookies to understand how people use the site, so we can improve it. They are set only if you accept. Privacy policy